About Cureety: Interview with CEO & Co-Founder François-Guirec Champoiseau
Seed Group Seed Group
977 subscribers
198 views
0

 Published On Dec 10, 2023

Exploring the inspiring journey of Cureety with founder Francois Guirec-Champoiseau. Watch this interesting interview as he unveils Cureety's mission to enhance the quality of life for patients worldwide.

TIMESTAMPS

00:00 – Introduction
00:02 – Can you share with us the journey of Cureety and what the initial foundation was based on?
01:08 – How do you achieve your goal of simplifying and optimising day-to-day patient monitoring?
02:41 – What technologies are you utilising to achieve your goals?
03:47 – What markets are you catering to? How do you look at the UAE and the Middle East in this context?
04:54 – What makes you unique in terms of catering to healthcare providers and medical researchers?
__________________________________________________

NEXT STEPS

👉 Read more about the partnership here: https://bit.ly/3GD8rMl

👉 Find out if you are eligible to become a royalty partner: https://bit.ly/3ViHh3S

__________________________________________________

About Cureety

Cureety is a MedTech startup that develops a digital remote monitoring platform for oncology patients, helping medical teams transform from reactive to proactive care management. Classified as a Class IIa Medical Device based on EU regulation, the Cureety platform enables the collection of patient-reported outcomes and implements proprietary algorithms adapted to all treatments and protocols available in onco-hematology. Cureety also recommends self-care services and medical content to help patients better understand symptoms and manage conditions daily. For clinical teams, the platform streamlines resources and prioritises care for the most vulnerable.

Cureety strives to enhance patients’ quality of life and strengthen the link with their medical team. Its technology improves the organization of care in the hospital without compromising the quality of care delivered by the medical teams. In addition to being the first oncology remote patient monitoring platform reimbursable in France by statutory insurance, Cureety is partnering with hospitals in France, Italy and Spain and has built a pan-European network of 60+ healthcare providers and research institutions. For more information, visit www.cureety.com.

About Seed Group

Over the past 20 years, the Seed Group has formed strategic alliances with leading global companies representing diverse regions and industries. These companies have propelled their business interests and goals in the Middle East & North Africa (MENA) region through the support and strong base of regional connections of the Seed Group. The Group’s goal is to create mutually beneficial partnerships with multinational organizations and to accelerate their sustainable market entry and presence within the MENA region. The Seed Group has been a key point in the success of all its partners in the region helping them reach their target customers and accelerate their businesses. The Private Office was established by Sheikh Saeed Bin Ahmed Al Maktoum to directly invest in or assist potential business opportunities in the region, which meet The Private Office’s criteria. For more information please visit https://seedgroup.com/.

______________________________________

🔗 FIND US ON LINKEDIN
Seed Group:   / seed-group  
The Private Office:   / the-private-office-of-sheikh-saeed-al-maktoum  

🔗 FOLLOW US ON INSTAGRAM
Seed Group:   / seedgroupme  

🔗 FOLLOW US ON X
Seed Group:   / seedgroupme  

For media and business inquiries: [email protected]

#digitalhealthcare #medtech #healthtech #oncology #telemedicine #digitalhealth #healthcareinnovations #ehealth #pharmatech #PharmaTech #patientcare #digitaltransformation #healthcaretechnology #pharmaceuticals #telehealthcare #MedicineInnovation #patientexperience #pharmaindustry #remotepatientmonitoring

show more

Share/Embed